Brind.

Acadia Healthcare CEO Christopher Hunter cited weaker Medicaid volumes, prompting questions from UBS and Raymond James analysts.

3 reports, 1 independent Updated Aug 13

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Acadia Healthcare CEO Christopher Hunter cited weaker Medicaid volumes, prompting questions from UBS and Raymond James analysts.

Who's involved

What this event is mainly about

Acadia Healthcare UBS

Keep exploring

The entities involved

Acadia Healthcare
multinational behavioral healthcare provider

Nothing else this week.
UBS
Swiss multinational investment bank and financial services company
- The Trump administration threatens tariffs on Switzerland, leading Switzerland to seek a new trade agreement with the US.Mon 00:13
- Following the acquisition of Credit Suisse, the Swiss parliament proposed new banking regulations for UBS.Sun 10:25

Coverage

Newest first; wire copies grouped

Aug 13StockStory5 Must-Read Analyst Questions From Acadia Healthcare’s Q2 Earnings Call Acadia Healthcare’s second quarter saw revenue and adjusted profit beat Wall Street expectations, but market reaction was sharp
Aug 13StockStoryACHC Q2 Deep Dive: Margin Pressures, Medicaid Volumes, and Strategy Shifts Under Scrutiny Behavioral health company Acadia Healthcare (NASDAQ:ACHC) beat Wall Street’s revenue expectations in Q2 CY202
Jul 4Unknown outlet